These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19284700)

  • 1. Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging.
    Tobinick EL; Chen K; Chen X
    BMC Res Notes; 2009 Feb; 2():28. PubMed ID: 19284700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2012 Jan; 9(1):99-109. PubMed ID: 22191562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
    Tobinick EL; Gross H
    BMC Neurol; 2008 Jul; 8():27. PubMed ID: 18644112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
    Tobinick E
    Medscape J Med; 2008 Jun; 10(6):135. PubMed ID: 18679537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central delivery of iodine-125-labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer's disease.
    Roerink ME; Groen RJ; Franssen G; Lemmers-van de Weem B; Boerman OC; van der Meer JW
    Alzheimers Res Ther; 2015 Nov; 7(1):70. PubMed ID: 26560086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid improvement in severe long COVID following perispinal etanercept.
    Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
    Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging of acute and chronic inflammation in living mice.
    Cao Q; Cai W; Li ZB; Chen K; He L; Li HC; Hui M; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1832-42. PubMed ID: 17541586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perispinal etanercept for treatment of Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2007 Dec; 4(5):550-2. PubMed ID: 18220520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
    Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS
    Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.
    Chen X; Liu S; Hou Y; Tohme M; Park R; Bading JR; Conti PS
    Mol Imaging Biol; 2004; 6(5):350-9. PubMed ID: 15380745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perispinal etanercept: a new therapeutic paradigm in neurology.
    Tobinick E
    Expert Rev Neurother; 2010 Jun; 10(6):985-1002. PubMed ID: 20518613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perispinal etanercept: potential as an Alzheimer therapeutic.
    Griffin WS
    J Neuroinflammation; 2008 Jan; 5():3. PubMed ID: 18186919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
    Tobinick EL; Gross H
    J Neuroinflammation; 2008 Jan; 5():2. PubMed ID: 18184433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET.
    Li ZB; Niu G; Wang H; He L; Yang L; Ploug M; Chen X
    Clin Cancer Res; 2008 Aug; 14(15):4758-66. PubMed ID: 18676745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.
    Yang YS; Zhang X; Xiong Z; Chen X
    Nucl Med Biol; 2006 Apr; 33(3):371-80. PubMed ID: 16631086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid PET/optical imaging of integrin αVβ3 receptor expression using a (64)Cu-labeled streptavidin/biotin-based dimeric RGD peptide.
    Kang CM; Koo HJ; An GI; Choe YS; Choi JY; Lee KH; Kim BT
    EJNMMI Res; 2015 Dec; 5(1):60. PubMed ID: 26518424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.
    Tobinick E
    CNS Drugs; 2009 Sep; 23(9):713-25. PubMed ID: 19689163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
    Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
    Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.